Destiny Pharma – Result of General Meeting and Total Voting Rights
Link to Full Article Destiny Pharma plc (“Destiny” or the “Company”) Result of General Meeting and Total Voting Rights Brighton, United Kingdom ‐ 26 November 2020: Destiny Pharma plc (AIM:DEST) a clinical stage biotechnology company focused on the development of novel products to prevent life threatening infections, announces that, at the General Meeting held earlier […]
